Difference between revisions of "Vendor:Cannevert Therapeutics Ltd."
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Made inactive.) |
Shawndouglas (talk | contribs) m (3 revisions imported) Tag: Reverted |
||
| Line 12: | Line 12: | ||
|foundation = | |foundation = | ||
|founder = | |founder = | ||
|defunct = | |defunct = | ||
|location_city = 101-2386 East Mall, Vancouver, British Columbia | |location_city = 101-2386 East Mall, Vancouver, British Columbia | ||
|location_country = Canada | |location_country = Canada | ||
| Line 32: | Line 32: | ||
|divisions = | |divisions = | ||
|subsid = | |subsid = | ||
|homepage = [ | |homepage = [https://anandia.ca/ anandia.ca] | ||
|linkedin = | |linkedin = [https://www.linkedin.com/company/anandia-labs/ https://www.linkedin.com/company/anandia-labs/] | ||
|footnotes = | |footnotes = | ||
|intl = No | |intl = No | ||
}} | }} | ||
'''Cannevert Therapeutics Ltd.''' | '''Cannevert Therapeutics Ltd.''' conducts ''[[Cannabis]]'' research and performs chemical ''Cannabis'' [[laboratory]] testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web |url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html |title=Laboratories licensed to conduct activities with cannabis |work=Health Canada |publisher=Government of Canada |date=17 August 2018 |accessdate=27 June 2019}}</ref> | ||
==History== | ==History== | ||
The company was formally founded in June 2014.<ref name="CACLACan">{{cite web |url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active |title=Cannevert Therapeutics Ltd |work=Canada's Business Registries |publisher=Canadian Association of Corporate Law Administrators |accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web |url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ |title=Veritas Presents Its Key Cannevert Scientists |publisher=Veritas Pharma, Inc |date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web |url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html |title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=TheNewswire |date=25 January 2017 |accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web |url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html |title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=GlobeNewswire |date=21 March 2018 |accessdate=28 June 2019}}</ref> | The company was formally founded in June 2014.<ref name="CACLACan">{{cite web |url=https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active |title=Cannevert Therapeutics Ltd |work=Canada's Business Registries |publisher=Canadian Association of Corporate Law Administrators |accessdate=28 June 2019}}</ref> In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.<ref name="VeritasVeritas16">{{cite web |url=http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/ |title=Veritas Presents Its Key Cannevert Scientists |publisher=Veritas Pharma, Inc |date=16 February 2016}}</ref> By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.<ref name="TNVeritas17">{{cite web |url=https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html |title=Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=TheNewswire |date=25 January 2017 |accessdate=28 June 2019}}</ref> In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."<ref name="GNWVeritas18">{{cite web |url=https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html |title=Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics |author=Veritas Pharma, Inc |work=GlobeNewswire |date=21 March 2018 |accessdate=28 June 2019}}</ref> In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of ''Cannabis''.<ref name="GNWVeritas19">{{cite web |url=https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html |title=Veritas Announces Restructuring of Cannevert Therapeutics Ltd. |author=Veritas Pharma, Inc |work=GlobeNewswire |date=15 May 2019 |accessdate=28 June 2019}}</ref> | ||
==Locations== | |||
The following laboratory locations are known. Services may vary among locations: | |||
* [http://www.cannevert.com/contact-us.html Cannevert Therapeutics] - Vancouver, British Columbia | |||
==Pricing== | |||
The company doesn't make its cannabis testing pricing public. | |||
==Additional information== | ==Additional information== | ||
| Line 52: | Line 58: | ||
<!---Place all category tags here--> | <!---Place all category tags here--> | ||
[[Category: | [[Category:Cannabis testing laboratories]] | ||
[[Category:Labs in British Columbia]] | |||
[[Category:Labs in Canada]] | |||
[[Category:Vendors]] | |||
Revision as of 22:29, 27 December 2023
| Type | Incorporated (limited) |
|---|---|
| Industry | Cannabis industry |
| Genre | Cannabis testing and research |
| Headquarters | 101-2386 East Mall, Vancouver, British Columbia, Canada |
| Number of locations | 1 |
| Area served | Canada |
| Key people | John Coleman |
| Services | Cannabis testing and research |
| Parent | Veritas Pharma, Inc. |
| Website | anandia.ca |
| https://www.linkedin.com/company/anandia-labs/ |
Cannevert Therapeutics Ltd. conducts Cannabis research and performs chemical Cannabis laboratory testing for the country's various cannabis programs.[1]
History
The company was formally founded in June 2014.[2] In December 2015, Veritas Pharma, Inc., "an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions," announced it would begin investing in Cannevert.[3] By May 2017, Veritas owned 80 percent of Cannevert, with an option to wholly buy the company on the table.[4] In March 2018, Veritas announced the full acquisition of Cannevert, stating that the acquisition "will further enhance and extend the Company's product offering through development of the most effective cannabis strains, advancing the science behind medical cannabis, providing distribution channels for the Companies patent protected IP (cultivars & strains) products and sell or license to cancer clinics, in Canada, the US, and Europe."[5] In May 2019, Veritas announced a restructuring and rebuilding of Cannevert, one that would include cutting and rehiring some researchers on a contract basis. Veritas described the move as one that would "reduce costs" while scaling to better tackle analytical testing of Cannabis.[6]
Locations
The following laboratory locations are known. Services may vary among locations:
- Cannevert Therapeutics - Vancouver, British Columbia
Pricing
The company doesn't make its cannabis testing pricing public.
Additional information
References
- ↑ "Laboratories licensed to conduct activities with cannabis". Health Canada. Government of Canada. 17 August 2018. https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html. Retrieved 27 June 2019.
- ↑ "Cannevert Therapeutics Ltd". Canada's Business Registries. Canadian Association of Corporate Law Administrators. https://beta.canadasbusinessregistries.ca/search/results?search={Cannevert}&status=Active. Retrieved 28 June 2019.
- ↑ "Veritas Presents Its Key Cannevert Scientists". Veritas Pharma, Inc. 16 February 2016. http://veritaspharmainc.com/2016/02/16/veritas-presents-its-key-cannevert-scientists/.
- ↑ Veritas Pharma, Inc (25 January 2017). "Veritas Pharma Places final Payment in Trust for the Acquisition of Cannevert Therapeutics". TheNewswire. https://thenewswire.com/archives/BKRFNmWA-veritas-pharma-places-final-payment-in-trust-for-the-acquisition-of-cannevert-therapeutics.html. Retrieved 28 June 2019.
- ↑ Veritas Pharma, Inc (21 March 2018). "Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics". GlobeNewswire. https://www.globenewswire.com/news-release/2018/03/21/1443325/0/en/Veritas-Pharma-Completes-the-100-Takeover-of-Cannevert-Therapeutics.html. Retrieved 28 June 2019.
- ↑ Veritas Pharma, Inc (15 May 2019). "Veritas Announces Restructuring of Cannevert Therapeutics Ltd.". GlobeNewswire. https://www.globenewswire.com/news-release/2019/05/15/1825699/0/en/Veritas-Announces-Restructuring-of-Cannevert-Therapeutics-Ltd.html. Retrieved 28 June 2019.
